Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

270.04 USD UNCHANGED
Streaming Delayed Price Updated: 8:46 AM EDT, Sep 25, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
Accelerating the Next Generation of Climate Policy and Protecting Human Health
Tags Corporate Social Responsibility Harvard public policy
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen to Invest $250 Million in a 20-year Initiative to Eliminate Its Use of Fossil Fuels and Improve Public Health
Tags Sustainable Development Goals Corporate Social Responsibility public health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen to Invest $250 Million in a 20-year Initiative to Eliminate its Use of Fossil Fuels and Improve Public Health
From GlobeNewswire News Releases
New Data at ACTRIMS-ECTRIMS Meeting Showcase Safety and Efficacy of Biogen’s Industry-Leading MS Portfolio
From GlobeNewswire News Releases
Livestream: Biogen’s New Corporate Commitment to Climate, Health and Equity
Tags NASDAQ:BIIB Climate Action Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Moves $10 Million To Black-Owned OneUnited, Joining the Fortune 500 Trend To 'Bank Black'
Tags OneUnited Bank Sustainable Finance & Socially Responsible Investment Biogen
From 3BL Media: Corporate Social Responsibility, Energy and Health News
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
From GlobeNewswire News Releases
OneUnited Bank, Fintech Pioneer, Announces $10 Million Deposit By Biogen To Support #BankBlack Movement
Bank chosen for cutting-edge technology and leading the way to close racial wealth gap 
From PR Newswire
Novel Cancer Treatments Arise as Scientists Search for Answers
FinancialBuzz.com News Commentary 
From PR Newswire
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Thinking about trading options or stock in Biogen Inc, Nio Inc, Zillow Group, Square Inc, or Apple?
InvestorsObserver issues critical PriceWatch Alerts for BIIB, NIO, ZG, SQ, and AAPL. 
From PR Newswire
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
From GlobeNewswire News Releases
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
From GlobeNewswire News Releases
Inspiring the Next Generation of Scientists in a New Way
Tags Biogen Lemelson/MIT Program MIT
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Doctors Reap the Benefits of Improving Diagnostic Capabilities
FinancialBuzz.com News Commentary 
From PR Newswire
Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s Disease
From GlobeNewswire News Releases
Biogen Names Michael McDonnell as Executive Vice President and Chief Financial Officer
From GlobeNewswire News Releases
JoVE and Biogen to Provide Somerville Public Schools with STEM Video Learning Resources
Tags Biogen Community Involvement Partnerships
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)
From GlobeNewswire News Releases
Initiation Of New Phase III Clinical Study (AHEAD 3-45) Of BAN2401 Preclinical (Asymptomatic) Alzheimer's Disease
The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, United... 
From PR Newswire
Fulfilling Our Commitment to Sustainability
Tags Climate Action Sustainability NASDAQ:BIIB
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer's Disease
From ACN Newswire
Advocacy Through Action: Protecting Massachusetts Nursing Home Residents and Staff from COVID-19
Tags COVID/19 Massachusetts Senior Care Association Wellness
From 3BL Media: Corporate Social Responsibility, Energy and Health News
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS
From GlobeNewswire News Releases
Thinking about trading options or stock in Biogen Inc, Alcoa Corp, Square Inc, Norwegian Cruise Line, or Boeing?
InvestorsObserver issues critical PriceWatch Alerts for BIIB, AA, SQ, NCLH, and BA. 
From PR Newswire
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer’s Disease
From GlobeNewswire News Releases
Increasing Diversity in Clinical Trials: A Collaboration with Tufts Center for the Study of Drug Development
Tags Health & Healthcare Diversity & Inclusion NASDAQ:BIIB
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Addressing Needs of Low-Income Populations
Tags COVID/19 Biogen Philanthropy & Cause Initiatives
From 3BL Media: Corporate Social Responsibility, Energy and Health News
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
From GlobeNewswire News Releases
The Hidden Face of MS
Tags Lauren Work Reduced Inequalities Biogen
From 3BL Media: Corporate Social Responsibility, Energy and Health News
< Previous 1 2 3 4 5 6 7 8 9
...
53 54 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.